👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
Trust score 8/100
Accepting new patients
Prof
Prof David Miles
English
10,086+
Patients seen
12
Years in practice
6
Publications
1
Languages spoken
About
Professor Miles is a consultant oncologist specialising in breast cancer treatment. They trained at University College London and pursued postgraduate education at King's College, University College, and Guy's and St Thomas' Hospitals. Professor Miles completed their doctorate in biological therapy of breast cancer at the Breast Unit of Guy's and St Thomas' Hospital.
Professor Miles has served as the Head of the Breast Cancer Biology Group at Guy's and St Thomas' and as Lead Clinician for breast cancer at Mount Vernon Cancer Centre. They are a Global Principal Investigator in clinical trials of biological therapies in the treatment of breast cancer. Professor Miles also serves on clinical trial steering and independent data monitoring committees for studies of novel therapies for the treatment of breast and other cancers.
Professor Miles advises the National Institute for Health and Clinical Excellence (NICE) on the adoption of new drugs being considered for breast cancer. They were invited by NICE to become a member of the committee to produce guidelines for the treatment of early-stage breast cancer and also sit on the NICE quality standards committee. Professor Miles is a module leader and lecturer at the Institute of Cancer Research and lectures internationally. They are an advisor to the charity Breast Cancer Care, a board member of the Cancer Vaccine Institute, and sit on the Central Institutional Review Board of Cancer Research UK.
Professor Miles has served as the Head of the Breast Cancer Biology Group at Guy's and St Thomas' and as Lead Clinician for breast cancer at Mount Vernon Cancer Centre. They are a Global Principal Investigator in clinical trials of biological therapies in the treatment of breast cancer. Professor Miles also serves on clinical trial steering and independent data monitoring committees for studies of novel therapies for the treatment of breast and other cancers.
Professor Miles advises the National Institute for Health and Clinical Excellence (NICE) on the adoption of new drugs being considered for breast cancer. They were invited by NICE to become a member of the committee to produce guidelines for the treatment of early-stage breast cancer and also sit on the NICE quality standards committee. Professor Miles is a module leader and lecturer at the Institute of Cancer Research and lectures internationally. They are an advisor to the charity Breast Cancer Care, a board member of the Cancer Vaccine Institute, and sit on the Central Institutional Review Board of Cancer Research UK.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Prof David Miles
Education & training
-
2004–2010 MD · Medicine and Surgery
-
2010–2014 Residency
-
2014–2015 Fellowship · Subspecialty training
Career & appointments
-
2014-09–2015-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of
Malpractice insurance:
AXA Healthcare Liability · 4,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 2,716 |
| Annual physical exam | 99395 | 450 |
| Vaccination administration | 90471 | 2,930 |
| Minor procedure (skin) | 17110 | 1,645 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 450.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 180.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 9 · i10: 10
-
European registry analysis of outcomes
DOI: 10.8471/euroclin.2025.0 · PMID: 39669668 · cited by 108
-
Outcomes of in adults — a multi-centre cohort
DOI: 10.2950/euroclin.2024.1 · PMID: 30635259 · cited by 62
-
European registry analysis of outcomes
DOI: 10.1360/euroclin.2023.2 · PMID: 31718555 · cited by 112
-
Outcomes of in adults — a multi-centre cohort
DOI: 10.1081/euroclin.2022.3 · PMID: 31038882 · cited by 74
Invited talks
- Practical updates in European Annual Congress () · Vienna · 2024 · invited
- Single-centre experience in National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2015
- national college of family doctors — Member · since 2015
- European Union of Medical Specialists (UEMS) — Member · since 2015
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to
- Awareness When should you see a ?
For international patients
- Coordinator
- Patient liaison · professor.david.miles@euroclinics.example